0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vaccine Adjuvants Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Othe-2172
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Vaccine Adjuvants Market Insights and Forecast to 2028

Global Vaccine Adjuvants Market Insights and Forecast to 2028

Code: QYRE-Othe-2172
Report
January 2022
115 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
Market Analysis and Insights: Global Vaccine Adjuvants Market

Due to the COVID-19 pandemic, the global Vaccine Adjuvants market size is estimated to be worth US$ 936.1 million in 2022 and is forecast to a readjusted size of US$ 1569.9 million by 2028 with a CAGR of 9.0% during the review period.

Fully considering the economic change by this health crisis, Aluminum Adjuvant accounting for % of the Vaccine Adjuvants global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Human Vaccine segment is altered to an % CAGR throughout this forecast period.
The top 5 global manufacturers of vaccine adjuvants are GSK, CSL Limited, Croda, SEPPIC, Novavax, which have a combined market share of about 55 percent. North America is the largest market, with a share about 38%, followed by Europe and Asia Pacific with the share about 27% and 22%.
Global Vaccine Adjuvants Scope and Segment
Vaccine Adjuvants market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Vaccine Adjuvants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Aluminum Adjuvant
Emulsions Adjuvant
Others

Segment by Application

Human Vaccine
Veterinary Vaccine

BY COMPANY

GSK
CSL Limited
Croda
SEPPIC
Novavax
SPI Pharma
Phibro
SDA BIO
Invivogen
Tj Kaiwei
OZ Biosciences
Brenntag Biosector
MVP Laboratories
Zhuoyue
Aphios

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Vaccine Adjuvants Product Introduction
1.2 Market by Type
1.2.1 Global Vaccine Adjuvants Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Aluminum Adjuvant
1.2.3 Emulsions Adjuvant
1.2.4 Others
1.3 Market by Application
1.3.1 Global Vaccine Adjuvants Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Human Vaccine
1.3.3 Veterinary Vaccine
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vaccine Adjuvants Sales Estimates and Forecasts 2017-2028
2.2 Global Vaccine Adjuvants Revenue Estimates and Forecasts 2017-2028
2.3 Global Vaccine Adjuvants Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Vaccine Adjuvants Sales by Region
2.4.1 Global Vaccine Adjuvants Sales by Region (2017-2022)
2.4.2 Global Sales Vaccine Adjuvants by Region (2023-2028)
2.5 Global Vaccine Adjuvants Revenue by Region
2.5.1 Global Vaccine Adjuvants Revenue by Region (2017-2022)
2.5.2 Global Vaccine Adjuvants Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Vaccine Adjuvants Sales by Manufacturers
3.1.1 Global Top Vaccine Adjuvants Manufacturers by Sales (2017-2022)
3.1.2 Global Vaccine Adjuvants Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaccine Adjuvants in 2021
3.2 Global Vaccine Adjuvants Revenue by Manufacturers
3.2.1 Global Vaccine Adjuvants Revenue by Manufacturers (2017-2022)
3.2.2 Global Vaccine Adjuvants Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Vaccine Adjuvants Revenue in 2021
3.3 Global Vaccine Adjuvants Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Vaccine Adjuvants Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vaccine Adjuvants Sales by Type
4.1.1 Global Vaccine Adjuvants Historical Sales by Type (2017-2022)
4.1.2 Global Vaccine Adjuvants Forecasted Sales by Type (2023-2028)
4.1.3 Global Vaccine Adjuvants Sales Market Share by Type (2017-2028)
4.2 Global Vaccine Adjuvants Revenue by Type
4.2.1 Global Vaccine Adjuvants Historical Revenue by Type (2017-2022)
4.2.2 Global Vaccine Adjuvants Forecasted Revenue by Type (2023-2028)
4.2.3 Global Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
4.3 Global Vaccine Adjuvants Price by Type
4.3.1 Global Vaccine Adjuvants Price by Type (2017-2022)
4.3.2 Global Vaccine Adjuvants Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Vaccine Adjuvants Sales by Application
5.1.1 Global Vaccine Adjuvants Historical Sales by Application (2017-2022)
5.1.2 Global Vaccine Adjuvants Forecasted Sales by Application (2023-2028)
5.1.3 Global Vaccine Adjuvants Sales Market Share by Application (2017-2028)
5.2 Global Vaccine Adjuvants Revenue by Application
5.2.1 Global Vaccine Adjuvants Historical Revenue by Application (2017-2022)
5.2.2 Global Vaccine Adjuvants Forecasted Revenue by Application (2023-2028)
5.2.3 Global Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
5.3 Global Vaccine Adjuvants Price by Application
5.3.1 Global Vaccine Adjuvants Price by Application (2017-2022)
5.3.2 Global Vaccine Adjuvants Price Forecast by Application (2023-2028)
6 North America
6.1 North America Vaccine Adjuvants Market Size by Type
6.1.1 North America Vaccine Adjuvants Sales by Type (2017-2028)
6.1.2 North America Vaccine Adjuvants Revenue by Type (2017-2028)
6.2 North America Vaccine Adjuvants Market Size by Application
6.2.1 North America Vaccine Adjuvants Sales by Application (2017-2028)
6.2.2 North America Vaccine Adjuvants Revenue by Application (2017-2028)
6.3 North America Vaccine Adjuvants Market Size by Country
6.3.1 North America Vaccine Adjuvants Sales by Country (2017-2028)
6.3.2 North America Vaccine Adjuvants Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Vaccine Adjuvants Market Size by Type
7.1.1 Europe Vaccine Adjuvants Sales by Type (2017-2028)
7.1.2 Europe Vaccine Adjuvants Revenue by Type (2017-2028)
7.2 Europe Vaccine Adjuvants Market Size by Application
7.2.1 Europe Vaccine Adjuvants Sales by Application (2017-2028)
7.2.2 Europe Vaccine Adjuvants Revenue by Application (2017-2028)
7.3 Europe Vaccine Adjuvants Market Size by Country
7.3.1 Europe Vaccine Adjuvants Sales by Country (2017-2028)
7.3.2 Europe Vaccine Adjuvants Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vaccine Adjuvants Market Size by Type
8.1.1 Asia Pacific Vaccine Adjuvants Sales by Type (2017-2028)
8.1.2 Asia Pacific Vaccine Adjuvants Revenue by Type (2017-2028)
8.2 Asia Pacific Vaccine Adjuvants Market Size by Application
8.2.1 Asia Pacific Vaccine Adjuvants Sales by Application (2017-2028)
8.2.2 Asia Pacific Vaccine Adjuvants Revenue by Application (2017-2028)
8.3 Asia Pacific Vaccine Adjuvants Market Size by Region
8.3.1 Asia Pacific Vaccine Adjuvants Sales by Region (2017-2028)
8.3.2 Asia Pacific Vaccine Adjuvants Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Vaccine Adjuvants Market Size by Type
9.1.1 Latin America Vaccine Adjuvants Sales by Type (2017-2028)
9.1.2 Latin America Vaccine Adjuvants Revenue by Type (2017-2028)
9.2 Latin America Vaccine Adjuvants Market Size by Application
9.2.1 Latin America Vaccine Adjuvants Sales by Application (2017-2028)
9.2.2 Latin America Vaccine Adjuvants Revenue by Application (2017-2028)
9.3 Latin America Vaccine Adjuvants Market Size by Country
9.3.1 Latin America Vaccine Adjuvants Sales by Country (2017-2028)
9.3.2 Latin America Vaccine Adjuvants Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vaccine Adjuvants Market Size by Type
10.1.1 Middle East and Africa Vaccine Adjuvants Sales by Type (2017-2028)
10.1.2 Middle East and Africa Vaccine Adjuvants Revenue by Type (2017-2028)
10.2 Middle East and Africa Vaccine Adjuvants Market Size by Application
10.2.1 Middle East and Africa Vaccine Adjuvants Sales by Application (2017-2028)
10.2.2 Middle East and Africa Vaccine Adjuvants Revenue by Application (2017-2028)
10.3 Middle East and Africa Vaccine Adjuvants Market Size by Country
10.3.1 Middle East and Africa Vaccine Adjuvants Sales by Country (2017-2028)
10.3.2 Middle East and Africa Vaccine Adjuvants Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GSK Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 CSL Limited
11.2.1 CSL Limited Corporation Information
11.2.2 CSL Limited Overview
11.2.3 CSL Limited Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CSL Limited Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Limited Recent Developments
11.3 Croda
11.3.1 Croda Corporation Information
11.3.2 Croda Overview
11.3.3 Croda Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Croda Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Croda Recent Developments
11.4 SEPPIC
11.4.1 SEPPIC Corporation Information
11.4.2 SEPPIC Overview
11.4.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 SEPPIC Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 SEPPIC Recent Developments
11.5 Novavax
11.5.1 Novavax Corporation Information
11.5.2 Novavax Overview
11.5.3 Novavax Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novavax Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novavax Recent Developments
11.6 SPI Pharma
11.6.1 SPI Pharma Corporation Information
11.6.2 SPI Pharma Overview
11.6.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 SPI Pharma Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 SPI Pharma Recent Developments
11.7 Phibro
11.7.1 Phibro Corporation Information
11.7.2 Phibro Overview
11.7.3 Phibro Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Phibro Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Phibro Recent Developments
11.8 SDA BIO
11.8.1 SDA BIO Corporation Information
11.8.2 SDA BIO Overview
11.8.3 SDA BIO Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 SDA BIO Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 SDA BIO Recent Developments
11.9 Invivogen
11.9.1 Invivogen Corporation Information
11.9.2 Invivogen Overview
11.9.3 Invivogen Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Invivogen Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Invivogen Recent Developments
11.10 Tj Kaiwei
11.10.1 Tj Kaiwei Corporation Information
11.10.2 Tj Kaiwei Overview
11.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Tj Kaiwei Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Tj Kaiwei Recent Developments
11.11 OZ Biosciences
11.11.1 OZ Biosciences Corporation Information
11.11.2 OZ Biosciences Overview
11.11.3 OZ Biosciences Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 OZ Biosciences Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 OZ Biosciences Recent Developments
11.12 Brenntag Biosector
11.12.1 Brenntag Biosector Corporation Information
11.12.2 Brenntag Biosector Overview
11.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Brenntag Biosector Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Brenntag Biosector Recent Developments
11.13 MVP Laboratories
11.13.1 MVP Laboratories Corporation Information
11.13.2 MVP Laboratories Overview
11.13.3 MVP Laboratories Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 MVP Laboratories Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 MVP Laboratories Recent Developments
11.14 Zhuoyue
11.14.1 Zhuoyue Corporation Information
11.14.2 Zhuoyue Overview
11.14.3 Zhuoyue Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Zhuoyue Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Zhuoyue Recent Developments
11.15 Aphios
11.15.1 Aphios Corporation Information
11.15.2 Aphios Overview
11.15.3 Aphios Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Aphios Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Aphios Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vaccine Adjuvants Industry Chain Analysis
12.2 Vaccine Adjuvants Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vaccine Adjuvants Production Mode & Process
12.4 Vaccine Adjuvants Sales and Marketing
12.4.1 Vaccine Adjuvants Sales Channels
12.4.2 Vaccine Adjuvants Distributors
12.5 Vaccine Adjuvants Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Vaccine Adjuvants Industry Trends
13.2 Vaccine Adjuvants Market Drivers
13.3 Vaccine Adjuvants Market Challenges
13.4 Vaccine Adjuvants Market Restraints
14 Key Findings in The Global Vaccine Adjuvants Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Vaccine Adjuvants Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Aluminum Adjuvant
    Table 3. Major Manufacturers of Emulsions Adjuvant
    Table 4. Major Manufacturers of Others
    Table 5. Global Vaccine Adjuvants Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Vaccine Adjuvants Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Vaccine Adjuvants Sales by Region (2017-2022) & (MT)
    Table 8. Global Vaccine Adjuvants Sales Market Share by Region (2017-2022)
    Table 9. Global Vaccine Adjuvants Sales by Region (2023-2028) & (MT)
    Table 10. Global Vaccine Adjuvants Sales Market Share by Region (2023-2028)
    Table 11. Global Vaccine Adjuvants Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Vaccine Adjuvants Revenue Market Share by Region (2017-2022)
    Table 13. Global Vaccine Adjuvants Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Vaccine Adjuvants Revenue Market Share by Region (2023-2028)
    Table 15. Global Vaccine Adjuvants Sales by Manufacturers (2017-2022) & (MT)
    Table 16. Global Vaccine Adjuvants Sales Share by Manufacturers (2017-2022)
    Table 17. Global Vaccine Adjuvants Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Vaccine Adjuvants Revenue Share by Manufacturers (2017-2022)
    Table 19. Vaccine Adjuvants Price by Manufacturers (2017-2022) &(USD/Kg)
    Table 20. Global Vaccine Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Adjuvants as of 2021)
    Table 22. Vaccine Adjuvants Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Vaccine Adjuvants Product Offered
    Table 24. Date of Manufacturers Enter into Vaccine Adjuvants Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
    Table 27. Global Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
    Table 28. Global Vaccine Adjuvants Sales Share by Type (2017-2022)
    Table 29. Global Vaccine Adjuvants Sales Share by Type (2023-2028)
    Table 30. Global Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Vaccine Adjuvants Revenue Share by Type (2017-2022)
    Table 33. Global Vaccine Adjuvants Revenue Share by Type (2023-2028)
    Table 34. Vaccine Adjuvants Price by Type (2017-2022) & (USD/Kg)
    Table 35. Global Vaccine Adjuvants Price Forecast by Type (2023-2028) & (USD/Kg)
    Table 36. Global Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
    Table 37. Global Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
    Table 38. Global Vaccine Adjuvants Sales Share by Application (2017-2022)
    Table 39. Global Vaccine Adjuvants Sales Share by Application (2023-2028)
    Table 40. Global Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Vaccine Adjuvants Revenue Share by Application (2017-2022)
    Table 43. Global Vaccine Adjuvants Revenue Share by Application (2023-2028)
    Table 44. Vaccine Adjuvants Price by Application (2017-2022) & (USD/Kg)
    Table 45. Global Vaccine Adjuvants Price Forecast by Application (2023-2028) & (USD/Kg)
    Table 46. North America Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
    Table 47. North America Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
    Table 48. North America Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
    Table 51. North America Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
    Table 52. North America Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Vaccine Adjuvants Sales by Country (2017-2022) & (MT)
    Table 55. North America Vaccine Adjuvants Sales by Country (2023-2028) & (MT)
    Table 56. North America Vaccine Adjuvants Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Vaccine Adjuvants Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
    Table 59. Europe Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
    Table 60. Europe Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
    Table 63. Europe Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
    Table 64. Europe Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Vaccine Adjuvants Sales by Country (2017-2022) & (MT)
    Table 67. Europe Vaccine Adjuvants Sales by Country (2023-2028) & (MT)
    Table 68. Europe Vaccine Adjuvants Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Vaccine Adjuvants Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
    Table 71. Asia Pacific Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
    Table 72. Asia Pacific Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
    Table 75. Asia Pacific Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
    Table 76. Asia Pacific Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Vaccine Adjuvants Sales by Region (2017-2022) & (MT)
    Table 79. Asia Pacific Vaccine Adjuvants Sales by Region (2023-2028) & (MT)
    Table 80. Asia Pacific Vaccine Adjuvants Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Vaccine Adjuvants Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
    Table 83. Latin America Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
    Table 84. Latin America Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
    Table 87. Latin America Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
    Table 88. Latin America Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Vaccine Adjuvants Sales by Country (2017-2022) & (MT)
    Table 91. Latin America Vaccine Adjuvants Sales by Country (2023-2028) & (MT)
    Table 92. Latin America Vaccine Adjuvants Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Vaccine Adjuvants Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
    Table 95. Middle East and Africa Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
    Table 96. Middle East and Africa Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
    Table 99. Middle East and Africa Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
    Table 100. Middle East and Africa Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Vaccine Adjuvants Sales by Country (2017-2022) & (MT)
    Table 103. Middle East and Africa Vaccine Adjuvants Sales by Country (2023-2028) & (MT)
    Table 104. Middle East and Africa Vaccine Adjuvants Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Vaccine Adjuvants Revenue by Country (2023-2028) & (US$ Million)
    Table 106. GSK Corporation Information
    Table 107. GSK Description and Major Businesses
    Table 108. GSK Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 109. GSK Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. GSK Recent Developments
    Table 111. CSL Limited Corporation Information
    Table 112. CSL Limited Description and Major Businesses
    Table 113. CSL Limited Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 114. CSL Limited Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. CSL Limited Recent Developments
    Table 116. Croda Corporation Information
    Table 117. Croda Description and Major Businesses
    Table 118. Croda Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 119. Croda Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Croda Recent Developments
    Table 121. SEPPIC Corporation Information
    Table 122. SEPPIC Description and Major Businesses
    Table 123. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 124. SEPPIC Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. SEPPIC Recent Developments
    Table 126. Novavax Corporation Information
    Table 127. Novavax Description and Major Businesses
    Table 128. Novavax Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 129. Novavax Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Novavax Recent Developments
    Table 131. SPI Pharma Corporation Information
    Table 132. SPI Pharma Description and Major Businesses
    Table 133. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 134. SPI Pharma Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. SPI Pharma Recent Developments
    Table 136. Phibro Corporation Information
    Table 137. Phibro Description and Major Businesses
    Table 138. Phibro Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 139. Phibro Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Phibro Recent Developments
    Table 141. SDA BIO Corporation Information
    Table 142. SDA BIO Description and Major Businesses
    Table 143. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 144. SDA BIO Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. SDA BIO Recent Developments
    Table 146. Invivogen Corporation Information
    Table 147. Invivogen Description and Major Businesses
    Table 148. Invivogen Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 149. Invivogen Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Invivogen Recent Developments
    Table 151. Tj Kaiwei Corporation Information
    Table 152. Tj Kaiwei Description and Major Businesses
    Table 153. Tj Kaiwei Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 154. Tj Kaiwei Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Tj Kaiwei Recent Developments
    Table 156. OZ Biosciences Corporation Information
    Table 157. OZ Biosciences Description and Major Businesses
    Table 158. OZ Biosciences Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 159. OZ Biosciences Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. OZ Biosciences Recent Developments
    Table 161. Brenntag Biosector Corporation Information
    Table 162. Brenntag Biosector Description and Major Businesses
    Table 163. Brenntag Biosector Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 164. Brenntag Biosector Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 165. Brenntag Biosector Recent Developments
    Table 166. MVP Laboratories Corporation Information
    Table 167. MVP Laboratories Description and Major Businesses
    Table 168. MVP Laboratories Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 169. MVP Laboratories Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 170. MVP Laboratories Recent Developments
    Table 171. Zhuoyue Corporation Information
    Table 172. Zhuoyue Description and Major Businesses
    Table 173. Zhuoyue Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 174. Zhuoyue Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 175. Zhuoyue Recent Developments
    Table 176. Aphios Corporation Information
    Table 177. Aphios Description and Major Businesses
    Table 178. Aphios Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 179. Aphios Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 180. Aphios Recent Developments
    Table 181. Key Raw Materials Lists
    Table 182. Raw Materials Key Suppliers Lists
    Table 183. Vaccine Adjuvants Distributors List
    Table 184. Vaccine Adjuvants Customers List
    Table 185. Vaccine Adjuvants Market Trends
    Table 186. Vaccine Adjuvants Market Drivers
    Table 187. Vaccine Adjuvants Market Challenges
    Table 188. Vaccine Adjuvants Market Restraints
    Table 189. Research Programs/Design for This Report
    Table 190. Key Data Information from Secondary Sources
    Table 191. Key Data Information from Primary Sources
List of Figures
    Figure 1. Vaccine Adjuvants Product Picture
    Figure 3. Global Vaccine Adjuvants Market Share by Type in 2021 & 2028
    Figure 3. Aluminum Adjuvant Product Picture
    Figure 4. Emulsions Adjuvant Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Vaccine Adjuvants Market Share by Application in 2021 & 2028
    Figure 7. Human Vaccine
    Figure 8. Veterinary Vaccine
    Figure 9. Vaccine Adjuvants Report Years Considered
    Figure 10. Global Vaccine Adjuvants Sales 2017-2028 (MT)
    Figure 11. Global Vaccine Adjuvants Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Vaccine Adjuvants Revenue 2017-2028 (US$ Million)
    Figure 13. Global Vaccine Adjuvants Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Vaccine Adjuvants Sales Market Share by Region (2017-2022)
    Figure 15. Global Vaccine Adjuvants Sales Market Share by Region (2023-2028)
    Figure 16. North America Vaccine Adjuvants Sales YoY (2017-2028) & (MT)
    Figure 17. North America Vaccine Adjuvants Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Vaccine Adjuvants Sales YoY (2017-2028) & (MT)
    Figure 19. Europe Vaccine Adjuvants Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Vaccine Adjuvants Sales YoY (2017-2028) & (MT)
    Figure 21. Asia-Pacific Vaccine Adjuvants Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Vaccine Adjuvants Sales YoY (2017-2028) & (MT)
    Figure 23. Latin America Vaccine Adjuvants Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Vaccine Adjuvants Sales YoY (2017-2028) & (MT)
    Figure 25. Middle East & Africa Vaccine Adjuvants Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Vaccine Adjuvants Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Vaccine Adjuvants in the World: Market Share by Vaccine Adjuvants Revenue in 2021
    Figure 28. Global Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Vaccine Adjuvants Sales Market Share by Type (2017-2028)
    Figure 30. Global Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
    Figure 31. Global Vaccine Adjuvants Sales Market Share by Application (2017-2028)
    Figure 32. Global Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
    Figure 33. North America Vaccine Adjuvants Sales Market Share by Type (2017-2028)
    Figure 34. North America Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
    Figure 35. North America Vaccine Adjuvants Sales Market Share by Application (2017-2028)
    Figure 36. North America Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
    Figure 37. North America Vaccine Adjuvants Sales Share by Country (2017-2028)
    Figure 38. North America Vaccine Adjuvants Revenue Share by Country (2017-2028)
    Figure 39. U.S. Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Vaccine Adjuvants Sales Market Share by Type (2017-2028)
    Figure 42. Europe Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Vaccine Adjuvants Sales Market Share by Application (2017-2028)
    Figure 44. Europe Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Vaccine Adjuvants Sales Share by Country (2017-2028)
    Figure 46. Europe Vaccine Adjuvants Revenue Share by Country (2017-2028)
    Figure 47. Germany Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 48. France Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Vaccine Adjuvants Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Vaccine Adjuvants Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Vaccine Adjuvants Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Vaccine Adjuvants Revenue Share by Region (2017-2028)
    Figure 58. China Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 61. India Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Vaccine Adjuvants Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Vaccine Adjuvants Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Vaccine Adjuvants Sales Share by Country (2017-2028)
    Figure 73. Latin America Vaccine Adjuvants Revenue Share by Country (2017-2028)
    Figure 74. Mexico Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Vaccine Adjuvants Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Vaccine Adjuvants Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Vaccine Adjuvants Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Vaccine Adjuvants Revenue Share by Country (2017-2028)
    Figure 83. Turkey Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
    Figure 86. Vaccine Adjuvants Value Chain
    Figure 87. Vaccine Adjuvants Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows multiple user to access the PDF.

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network

RELATED REPORTS

Global and United States Sexually Transmitted Disease Therapeutics Market Report Forecast 2022 2028
Global and United States Sexually Transmitted Disease Therapeutics Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Othe-412
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Vaccine Technologies Market Report Forecast 2022 2028
Global and United States Vaccine Technologies Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-30Z5715
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Healthcare Acquired Infection Market Report Forecast 2022 2028
Global and United States Healthcare-Acquired Infection Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-24Z5686
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Viral Vector Vaccines Market Report Forecast 2022 2028
Global and United States Viral Vector Vaccines Market Report & Forecast 2022-2028

Viral vector vaccines combine many of the positive qualities of DNA vaccines with those of live attenuated vaccines.Market Analysis and Insights Global and United States Viral Vector Vaccines MarketThis report focuses on global and United States Viral Vector Vaccines market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Viral Vector Vaccines market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-30G10233
Tue Jun 07 00:00:00 UTC 2022

Add to Cart